Key result
Selective intra-arterial streptokinase achieves significant lysis in ~80% of cases and provides clinical benefit.
Why the study?
Does selective intra-arterial infusion of streptokinase improve lysis and clinical outcomes in patients with acute peripheral arterial thromboembolic disease?
Population
n=45 patients (50 arteries) with acute peripheral arterial thromboembolic conditions.
Design
Case_series
Authors
Loading...
Hypothesis-generating for intra-arterial streptokinase in acute peripheral arterial occlusion; randomized trials needed before clinical adoption.
Observational (n=45)
Does selective intra-arterial infusion of streptokinase improve lysis and clinical outcomes in patients with acute peripheral arterial thromboembolic disease?
Selective intra-arterial infusion of streptokinase is a moderately effective and safe technique for acute peripheral arterial thromboembolic disease, achieving high rates of lysis with an acceptable safety profile.
Mori et al. (1983) conducted an observational in acute thromboembolic conditions (n=45). Selective intra-arterial infusion of streptokinase was evaluated on Significant lysis. Selective intra-arterial infusion of streptokinase achieved significant lysis in 80% of cases and clinical benefit in 74% of patients, with major hemorrhages occurring in 8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: